#layerFFYE14PGYNXZY5D1SNFX65BMNKRESFZD .search_btn {border: 0px solid #fff;border-radius: 0px;color: #fff;}#layerFFYE14PGYNXZY5D1SNFX65BMNKRESFZD .search_btn a {color: #fff!important;}#layerFFYE14PGYNXZY5D1SNFX65BMNKRESFZD .search_btn:hover {background-color: #000!important;border-color: #fff;color: #fff;}#layerFFYE14PGYNXZY5D1SNFX65BMNKRESFZD .search_btn:hover a {color: #fff!important;}

 

 

Group profile

All for drug safety

Hunan Er-kang Pharmaceutical Co., Ltd., founded in 2003, is the largest and most comprehensive pharmaceutical excipient company in China, boasting the widest range of products and the most advanced technology (Stock Code: SZ.300267). It is a leading enterprise in the high-tech sector and a pioneer in the pharmaceutical excipient industry, being the primary architect of China’s pharmaceutical excipient standards and the first to industrialize starch capsules.

The company currently offers 127 types of pharmaceutical excipients, 73 active pharmaceutical ingredients (APIs), and has 282 approvals for finished drug products. Among these, the starch-based plant capsule is a core product with global exclusive intellectual property rights, holding over 90 patents. The company’s products are exported to nearly 40 countries and regions worldwide. Erkang has received multiple accolades, including being named a ‘National Torch Program Key High-tech Enterprise’, ‘China’s Most Investment-worthy Pharmaceutical Listed Company’, ‘Top 100 Enterprises in China’s Pharmaceutical Industry’, and inclusion in the ‘Xinhua News Agency National Brand Project’.

  • 2,003

    Established in 2003

  • 70

    With 70 years of pharmaceutical experience

  • 200

    Global international research and development patents

  • 4,000

    Serve more than 4000 customers

Excipients

We possess 129 registration approvals for pharmaceutical excipients, covering pharmaceutical glycerin, ethanol, propylene glycol, sodium hydroxide and so on. We are committed to the research and development of new pharmaceutical excipients. 

Export of APIs

We focus on four highly challenging chemical process flows, namely nitration, chlorination, sulfonation and hydrogenation reduction, and provide characteristic active pharmaceutical ingredients and intermediates such as ursodeoxycholic acid, aminophylline, caffeine, sodium citrate, sulfadiazine, etc., to meet the diversified needs of our customers.

Our service

We are a company integrating industry, research and trade. We possess production workshops that meet GMP qualifications, as well as a number of professional talents who have been engaged in pharmaceutical research and development, production and testing for a long time. We are committed to building a one-stop comprehensive service platform covering the whole pharmaceutical process, aiming to offer a greater variety of products and services, on a larger scale and with more complete supporting facilities. 

  • Standard products

    We provide production and research and development of standard products

    Supplier audit

    The procurement principles of fairness, impartiality and sincere cooperation.

  • Inspection and testing

    Strict inspection and testing of products

    Product customization

    Customization services for non-standard products.

Our advantage

News & Events

[Industry News] The National Standing Committee has reviewed and approved the "Implementation Plan for Supporting the Development of Innovative Drugs

In the 2024 government work report, innovative drugs were mentioned for the first time, fully demonstrating the country's determination and confidence in innovative drugs. Recently, innovative drugs…
2024-07-08 16:32

Explore more →

【 Current Affairs Erkang 】 International Brilliant Erkang Pharmaceutical's Advantageous Products Make Strong Waves at Two Major International Industry
On October 24-26, 2023, CPHI Wordwide and SupplySide West, two major international industry events, were grandly opened in Spain and the United States, respectively.
2023-10-27 17:56

Explore more →

Interpretation of the Implementation Plan for Promoting High Quality Development of the API Industry: In response to the needs of the times, we will f

Recently, the National Development and Reform Commission and the Ministry of Industry and Information Technology jointly issued the "Implementation Plan for Promoting the High Quality Development of t
2021-11-17 17:23

Explore more →

Contact us

If you are interested in our products and services, please feel free to contact us anytime!